Cipla Partners with American Lung Association to Support Lung Health and Research

The American Lung Association in New York is proud to welcome Cipla back as the lead sponsor of the 2025 LUNG FORCE Walk New York City. As this year’s Breathe Free Sponsor, Cipla continues its commitment to ‘Caring For Life’ by providing high-quality medicines, improving lung health and supporting those impacted by lung disease through advocacy, education, and research. 

This Walk will once again take place at the iconic South Street Seaport, Pier 16, on Saturday, May 17. More than 1,200 participants will walk a 1-mile or 3-mile scenic route with stunning views of the Brooklyn Bridge, celebrating survivors, supporting those currently facing lung disease, and remembering loved ones lost.

Registration is now open at LUNGFORCE.org/nyc

“We’re incredibly grateful to Cipla for their continued support as a returning sponsor of the LUNG FORCE Walk NYC,” said Erica Masin, Executive Director for the American Lung Association in Metro New York. “Corporate citizens like Cipla play a vital role in making events like this possible — helping us raise critical funds for research, education, and advocacy efforts that advance lung health and save lives. Their partnership, along with the dedication of our walkers, volunteers, and medical community, helps turn our mission into meaningful action.”

“Supporting the American Lung Association’s LUNG FORCE Walk is a meaningful way for our Cipla North America team to stand behind a cause that reflects our values of ‘Caring for Life’ and advancing respiratory health. A global leader in lung health, Cipla celebrates 90 years of making a positive difference in people’s lives. Each year of participating in this walk reminds us how rewarding it is when community, purpose, and compassion come together.” – Marc Falkin, CEO, Cipla North America.

Since its inception, the LUNG FORCE Walk NYC has provided over $2 million in critical funding for research, education, and advocacy efforts for lung cancer, chronic lung diseases and respiratory illnesses.

The event will include an impactful opening ceremony where LUNG FORCE Heroes will share their stories, and the crowd will share in a fitness warm-up.  All participants will also have the opportunity to complete a LUNG FORCE Action passport that encourages lung health education and join a Party on the Pier after the walk!  

More information and registration are available at LUNGFORCE.org/nyc.

About Cipla
Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets. Our strengths in the respiratory, anti-retroviral, urology, cardiology, anti-infective and CNS segments are well-known. Our 46 manufacturing sites around the world produce 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to our 80+ markets. For nearly nine decades, making a difference to patients has inspired every aspect of Cipla’s work. A responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of ‘Caring for Life’ and deep-rooted community links wherever it is present make it a partner of choice to global health bodies, peers and all stakeholders. 
Cipla USA, the wholly owned subsidiary of Cipla, is a respiratory leader, ranking #2 in inhaler sales globally and in the top 3 for US generic respiratory sales (IQVIA TRx data as of February 2025). For more information about Cipla and its commitment to respiratory health, please visit Cipla USA website at www.ciplausa.com